SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022202
Filing Date
2022-08-12
Accepted
2022-08-12 08:39:41
Documents
96
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1413422
2 ex31-1.htm EX-31.1 11040
3 ex32-1.htm EX-32.1 7638
  Complete submission text file 0001493152-22-022202.txt   6786042

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfri-20220630.xsd EX-101.SCH 54741
5 XBRL CALCULATION FILE bfri-20220630_cal.xml EX-101.CAL 72309
6 XBRL DEFINITION FILE bfri-20220630_def.xml EX-101.DEF 227583
7 XBRL LABEL FILE bfri-20220630_lab.xml EX-101.LAB 412127
8 XBRL PRESENTATION FILE bfri-20220630_pre.xml EX-101.PRE 331416
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1140446
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 221157962
SIC: 2834 Pharmaceutical Preparations